Pharmaceutical Biotechnology Experts are professionals who apply advanced biological and biotechnological methods to develop new drugs and therapies. They focus on the use of living organisms, cells, and biological processes to create biologics such as monoclonal antibodies, therapeutic proteins, and vaccines. By harnessing the power of biotechnology, these experts are pioneering new treatments for complex diseases like cancer, diabetes, and genetic disorders. Their work plays a pivotal role in developing biologic therapies that offer personalized and targeted treatment options, improving the effectiveness and safety of healthcare. With the integration of cutting-edge technologies, these experts are at the forefront of developing next-generation treatments that can significantly alter disease progression.
These are work at the intersection of biology, chemistry, and pharmacology, using tools such as genetic engineering, cell culture, and gene editing techniques like CRISPR. Their primary goal is to optimize the production of high-quality biologic drugs while ensuring they are safe, scalable, and cost-effective for widespread use. Pharmaceutical biotechnology experts also navigate the complexities of regulatory approval processes, ensuring that new therapies meet the necessary standards for patient safety and efficacy. With the rise of biologic drugs in modern medicine, these professionals are critical in driving the innovation that addresses unmet medical needs and helps transform the future of healthcare.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada